Home > Insights > Blogs > Tracking Cannabis > "cannabis-politics"

Tracking Cannabis

Tracking Cannabis

(By accessing, browsing or using the pages below, you agree to the Blog Conditions of Use/Disclaimer available under "Links.")


Rohrabacher–Blumenauer Amendment included in omnibus FY 2018 spending bill

March 28, 2018

On March 23, 2018, the federal omnibus spending bill was signed into law, which included an updated version of the Rohrabacher-Blumenauer Amendment prohibiting the use of DOJ funds for Controlled Substances Act enforcement in states with a medical cannabis program. READ MORE

Big month ahead for federal cannabis policy in Congress

February 6, 2018

The clock is ticking on stopgap legislation shielding the medical cannabis industry from potential federal intervention. With protections under the Rohrabacher-Blumenauer amendment set to expire on Feb. 9, our Lobbying & Policy Practice breaks down what's in store for federal cannabis policy before Congress in the coming weeks. READ MORE

AG's latest remarks signal no outright campaign against cannabis yet

March 20, 2017

U.S. Attorney General Jeff Sessions continues to tune his stance on legalized medical and recreational marijuana in public comments. His latest proclamation in mid-March gives hope to the industry on medical use while leaving recreational use susceptible to a crackdown. READ MORE

Thompson Coburn advises clients on state laws governing the business of cannabis to facilitate compliance with those state laws. Federal laws concerning cannabis currently conflict with state laws in states that have legalized cannabis or possession of cannabis. Although federal enforcement policy may at times defer to these states’ laws and not enforce conflicting federal laws, interested businesses and individuals should be aware that compliance with state law in no way assures compliance with federal law, and there is a risk that conflicting federal laws may be enforced in the future. In addition to this Cannabis-specific note, readers should review Thompson Coburn’s Conditions of Use / Disclaimers page containing other important information.